| 胰岛素泵与利拉鲁肽治疗老年超重2型糖尿病的疗效与安全性 |
| |
| 引用本文： | 张爽.胰岛素泵与利拉鲁肽治疗老年超重2型糖尿病的疗效与安全性[J].中国医疗器械信息,2021(7):142-143. |
| |
| 作者姓名： | 张爽 |
| |
| 作者单位： | 中国医科大学第八临床学院鞍钢集团公司总医院 |
| |
| 摘 要： | 目的:探讨胰岛素泵与利拉鲁肽治疗在老年超重2型糖尿病患者中的应用效果。方法:将68例老年超重2型糖尿病患者分为观察组(胰岛素泵)和对照组(利拉鲁肽)各34例,对比其治疗效果。结果:与对照组相比,观察组患者的治疗有效率(94.12%>73.53%)、SF-36评分((78.82±4.24)分>(69.14±5.16)分)相对更高(P<0.05),并发症发生率(8.82%<32.35%)、FBG((6.29±1.05)<(8.04±1.16)mmol/L)、2h PBG((8.74±1.38)<(10.39±1.57)mmol/L)、BMI((23.51±2.04)<(27.75±2.36)kg/m2)相对更低(P<0.05)。结论:老年超重2型糖尿病的临床治疗,胰岛素泵治疗在疗效和安全性方面具有显著优势。
|
| 关 键 词： | 利拉鲁肽 胰岛素泵治疗 老年超重2 型糖尿病 疗效 安全性 |
Efficacy and Safety of Liraglutide and Insulin Pump in the Treatment of Elderly Overweight Type 2 Diabetes |
| |
| ZHANG Shuang.Efficacy and Safety of Liraglutide and Insulin Pump in the Treatment of Elderly Overweight Type 2 Diabetes[J].China Medical Devices Information,2021(7):142-143. |
| |
| Authors: | ZHANG Shuang |
| |
| Institution: | (General Hospital of Angang Group Company,the Eighth Clinical College of China Medical University,Liaoning Anshan 114002) |
| |
| Abstract: | Objective:To investigate the effect of insulin pump and Lilarubicin in elderly patients with overweight type 2 diabetes mellitus.Methods:68 elderly patients with overweight type 2 diabetes mellitus were divided into observation group(n=34)and control group(n=34).Results:Compared with the control group,the treatment effective rate(94.12%>73.53%)and SF-36 score(78.82±4.24)points>(69.14±5.16)points]of the observation group were relatively higher(P<0.05),Complication rate(8.82%<32.35%),FBG(6.29±1.05)mmol/L<(8.04±1.16)mmol/L],2h PBG(8.74±1.38)mmol/L<(10.39±1.57)mmol/L],BMI(23.51±2.04)kg/m2<(27.75±2.36)kg/m2]relatively lower(P<0.05).Conclusion:The clinical treatment and insulin pump therapy of overweight type 2 diabetes mellitus in the elderly have significant advantages in efficacy and safety. |
| |
| Keywords: | liraglutide insulin pump therapy elderly overweight type 2 diabetes efficacy safety |
| 本文献已被 维普 等数据库收录！ |
